What Happened?
Charlottesville, VA-based Diffusion-Pharmaceuticals Appointed David Kalergis as Chairman and Chief Executive Officer
About the Company
Neuralink is a team of exceptionally talented people. We are creating the future of brain-machine interfaces: building devices now that will help people with paralysis and inventing new technologies that will expand our abilities, our community, and our world. Our goal is to build a system with at least two orders of magnitude more communication channels (electrodes) than current clinically-approved devices. This system needs to be safe, it must have fully wireless communication through the skin, and it has to be ready for patients to take home and use on their own. Our device, called the Link, will be able to record from 1024 electrodes and is designed to meet these criteria.
About the Person
David Kalergis is Chairman and Chief Executive Officer at Diffusion Pharmaceuticals. Previously, David held various senior HR leadership roles in the industry.
Info Source
News
Short Profile